SEATTLE, Sept. 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) announced today that it will host an investor day in Milan, Italy on October 3, 2008. The investor day will provide an update from executive management on key strategic initiatives and regulatory milestones for the Company. The meeting will be an invitation-only event. A webcast and live teleconference of the event will be available to all investors. Additional event details will provided in the near future.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.celltherapeutics.com.
CONTACT: media, Dan Eramian, +1-206-272-4343, +1-206-854-1200, cell,
media@ctiseattle.com, or Ed Bell, +1-206-272-4345, or Lindsey Jesch,
+1-206-272-4347, +1-206-272-4434, fax, invest@ctiseattle.com, all for Cell
Therapeutics, Inc.
Web site: http://www.celltherapeutics.com/
